Evidence map›Paper›PMID 23642654›Full record

ArticleThrombosis research2013

Hydrodynamic characterization of recombinant human fibrinogen species.

Bertrand Raynal, Barbara Cardinali, Jos Grimbergen, Aldo Profumo, Susan T Lord, Patrick England, Mattia Rocco

Open access · greenAbstract read
In one paragraph

Article in Thrombosis research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 19 citations in OpenAlex.

  1. Fibrin as a Versatile Fibrous Biopolymer.Sub-cellular biochemistry · 2026
    Review
  2. Review
  3. Article
  4. Atomic Structural Models of Fibrin Oligomers.Structure (London, England : 1993) · 2018
    Article
  5. Article
  6. Fibrin Formation, Structure and Properties.Sub-cellular biochemistry · 2017
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Bertrand RaynalInstitut Pasteur, Protéopole, Plate-Forme de Biophysique des Macromolécules et de leurs Interactions, CNRS UMR 3528, 25 Rue du Docteur Roux, 75724 Paris Cedex 15, France. bertrand.raynal@pasteur.fr
Barbara Cardinali
Jos Grimbergen
Aldo Profumo
Susan T Lord
Patrick England
Mattia Rocco
Centre National de la Recherche Scientifique · FROspedale Policlinico San Martino · ITUniversity of North Carolina at Chapel Hill · US

Funding

MUTAGENIC STUDIES OF FIBRINOGEN ALPHA CHAIN FUNCTIONR01HL031048 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI LORD, SUSAN T · 1987 to 2010
$3.5M
A GENETIC APPROACH TO THE FIBRINOGEN-FIBRIN CONVERSIONR23HL031048 · NHLBI · UNIVERSITY OF NORTH CAROLINA CHAPEL HILL · PI LORD, SUSAN T · 1985 to 1986
–
NHLBI NIH HHS HL031048NHLBI NIH HHS R01 HL031048
6 · The paper itself

Abstract

introductionFibrinogen is a key component of the blood coagulation system and plays important, diverse roles in several relevant pathologies such as thrombosis, hemorrhage, and cancer. It is a large glycoprotein whose three-dimensional molecular structure is not fully known. Furthermore, circulating fibrinogen is highly heterogeneous, mainly due to proteolytic degradation and alternative mRNA processing. Recombinant production of human fibrinogen allows investigating the impact on the three-dimensional structure of specific changes in the primary structure.

methodsWe performed analytical ultracentrifugation analyses of a full-length recombinant human fibrinogen, its counterpart purified from human plasma, and a recombinant human fibrinogen with both Aα chains truncated at amino acid 251, thus missing their last 359 amino acid residues.

resultsWe have accurately determined the translational diffusion and sedimentation coefficients (Dt(20,w)(0), s(20,w)(0)) of all three species. This was confirmed by derived molecular weights within 1% for the full length species, and 5% for the truncated species, as assessed by comparison with SDS-PAGE/Western blot analyses and primary structure data. No significant differences in the values of Dt(20,w)(0) and s(20,w)(0) were found between the recombinant and purified full length human fibrinogens, while slightly lower and higher values, respectively, resulted for the recombinant truncated human fibrinogen compared to a previously characterized purified human fibrinogen fragment X obtained by plasmin digestion.

conclusionsFull-length recombinant fibrinogen is less polydisperse but hydrodynamically indistinguishable from its counterpart purified from human plasma. Recombinant Aα251-truncated human fibrinogen instead behaves differently from fragment X, suggesting a role for the Bβ residues 1-52 in inter-molecular interactions. Overall, these new hydrodynamic data will constitute a reliable benchmark against which models of fibrinogen species could be compared.

Indexed as

Blotting, WesternChromatography, Reverse-PhaseElectrophoresis, Polyacrylamide GelFibrin Fibrinogen Degradation ProductsFibrinogenHumansHydrodynamicsRecombinant ProteinsUltracentrifugationFibrin Fibrinogen Degradation ProductsFibrinogenfibrinogen fragment XRecombinant ProteinsAnalytical Ultracentrifugationanalytical ultracentrifugation sedimentation velocityAUC-SVBlood Coagulationchicken plasma FGcpFGFGfibrinogenfibrinopeptide Afibrinopeptide BFpAFpBhpFrX-FGhpHMW-FGhrHMW-FGhrα251-FGhuman plasma FG fragment Xhuman plasma high molecular weight FGhuman recombinant FG with Aα chains truncated after residue 251human recombinant high molecular weight FGHydrodynamicsRecombinant Fibrinogen

Identifiers

PMID23642654
PMCPMC3742573
OpenAlexW2110721047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.